Professor of Cell and Molecular Biology, Department of Surgery, The Houston Methodist Research Institute, Weill Cornell Medical College
Tenured Associate Professor, Department of Zoology, the University of Warsaw
Research Associate, Department of Biology, Carleton University in Ottawa
Associate Professor, Department of Biochemistry and Molecular Biology there in 2006.
Distinguished Fellow of the Kosciuszko Foundation in 2014 
Fulbright Senior Specialist Grant Award in 2003
Research Scientist in University of Texas M.D. Anderson Cancer Center in 1987
The MRC Biotechnology Training Award from Dalhousie University in1985
The AHFMR Research Award from the University of Calgary in 1982

Professor of Institute of Genetics and Development of Rennes, Faculty of Medicine, University of Rennes
Director of Dynamics and Mechanics of Epithelia Group, Institute of Genetics and Development of Rennes (IGDR)
Director of National Centre for Scientific Research (CNRS), Faculty of Medicine
Full-time Researcher at the National Centre for Scientific Research (CNRS)

Professor and Head of the Department of Neurology, St. Joseph Hospital Berlin‑Weißensee (Alexianer), Germany, with authorization to train for certification in Neurology (36 months)

Chief Physician (Chefarzt), Clinic for Neurology, St. Joseph Hospital Berlin‑Weißensee, specializing in Multiple Sclerosis and Parkinson’s disease care and research

Recognized as a leading regional and national expert in MS and Parkinson’s disease, based on long-term contributions and clinic development

Awarded the PRIMO MEDICO quality seal (2019 and ongoing), signifying top-tier medical expertise in the German-speaking region

Led the designation of the clinic as a DMSG-certified MS Centre of Excellence (as of October 1, 2019), awarded by the German Multiple Sclerosis Society

Medical Director of GenesisCare Spain, Spain. Interests are Prostate Cancer, Lung Cancer, Adaptive radiotherapy , Next Generation Imaging and Molecular Biomarkers.

Resident (AIOS) - Gastroenterology & Hepatology, Leiden University Medical Centre / HMC in 2019-present
SHO - Transplant Hepatology/General Gastroenterology, Leiden University Medical Centre in 2018
Visiting Scientist - University of Calgary in 2014

• University Distinguished Professor, Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center
• Former Chairman (2012-2024), Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center.
• Fellow, Academy of Toxicological Sciences (ATS)
• Fellow, American Association for the Study of Liver Disease (FASLD)
• President of the Clinical and Translational Specialty Section of SOT (2023-24)
• Translational Impact Award, Society of Toxicology, 2019.

Voluntary Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
Diplomate, Faculty Member, and Advisor, Medical Wellness Association, Houston, TX, USA
Founder and President, Dr. Lewis Nutrition

• Visiting Fellow, Oral and Maxillofacial Surgery / Oral Pathology

Founder,GraphPad Software
Statistics Editor, Molecular Pharmacology
Member Board of Trustees, Cancer Angels of San Diego
Member Board of Trustees, Center for American Culture and Ideas
Member Board of Trustees, Hastings bioethics center
Board Member, New Roads School
Postdoctoral fellow, then Assistant professor, UCSD Pharmacology

Assistant Professor
Department of Surgery NUTRIM School of Nutrition and Translational Research in Metabolism Faculty of Health, Medicine and Life Sciences

Director and professor, Health Mangement Institute, Chinese PLA General Hospital, Beijing, China

Elsevier's Top 0.5% (2023) and Top 1% (2021-2022) Scientists
Adjunct Professor at the University of Calgary, Calgary, Canada. 
Editor of mBio, an Associate Editor of Virology Journal, etc.
Awards: Hundred-Talent Program of the Chinese Academy of Sciences
Top 25 reviewers for the Journal of Virology (2019, 2020, 2021, 2022)
the Publons Top 1% Peer Reviewers (2019-2020)
Excellent Editors of ASM (mBio), Springer Nature and Frontiers. 

 Director U.O.C. Oncologia, San Giovanni Di Dio Hospital , Italy

Department Head, Mechanical Engineering, Texas A&M University, College Station, Texas, USA
Professor, Mechanical Engineering, Texas A&M University, College Station, Texas, USA
International Society for Optical Engineering (SPIE) Senior Member, 2024
American Institute for Medical and Biological Engineering (AIMBE) Fellow, 2023
American Association for the Advancement of Science (AAAS) Member, 2023
American Society for Engineering Education (ASEE) Member, 2022
Emeritus/Adjunct Professor of Mechanical Engineering UC Riverside, 2021
American Society of Mechanical Engineering (ASME) Fellow, 2020
National Academy of Engineering of Mexico, 2019
STAR Award: Educator of the Year, Society of Hispanic Professionals and Engineers (SHPE), 2014
American Society for Lasers in Medicine and Surgery (ASLMS) Fellow, 2003
Research Scientist Development Award, 2002-2007

Professor, Saitama Medical University

Associate Professor, Medicine-Cardiology, Baylor College of Medicine, Houston, USA
2023 Top Doctor, Houstonia Magazine
Fellow - American College of Cardiology
Fellow - The Society for Cardiovascular Angiography & Interventions (SCAI)

Professor of Clinical Practice, School of Graduate Studies, Lingnan University, Tuen Mun, Hong Kong, China

Professor, Division of Discovery Science, University of Texas Health Science Center, GSBS, Houston, TX
Professor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX
Co-Director, Department of Center for Environmental and Molecular Carcinogenesis (CEMC), The University of Texas MD Anderson Cancer Center, Smithville, TX, 2012 - 2016
Associate Member, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX, 2019 - Present
Consultant, Bayer Medical Oncology Division, Houston, Texas, 2002 - 2003
Faculty Member, Center for Molecular Carcinogenesis and Toxicology (CMTC), The University of Texas at Austin, Austin, TX, 2000 - Present
Assistant Biologist, Science Park- Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX, 1987 - 1988
Research Associate, Department of Carcinogenesis, Science Park- Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX, 1985 - 1986
Project Investigator, Science Park- Research Division, The University of Texas MD Anderson Cancer Center, Smithville, TX, 1983 - 1985
Research Fellow, Atomic Energy Commission, Buenos Aires, 1980 - 1983

Institutional Committee Activities
Member, Research Integrity Matter MDA 2023-11 Inquiry Committee, 2024 - Present
Judge, Oral Skills Presentation competition for GSBS Student Research Day (GSRD), 2019
Member, MDACC, DCIS Tissue Utilization Committee, 2018
Basic Committee Reviewer, MDACC, Institutional Research Grant (IRG) Committee, 2017 - Present
Member, MDACC, Multidisciplinary Research Advisory Committee (MRAC), 2016 - 2023
Member, MDACC, Institutional Biosafety Committee, 2011 - 2015
Member, Department of Epigenetics and Molecular Carcinogenesis, ARFAC Committee, 2010
Representative, Department of Molecular Carcinogenesis, Faculty Senate Department, 2010 - 2012
Member, GSBS Molecular Carcinogenesis Program, Steering Committee, 2010 - 2011
Member, GSBS Molecular Carcinogenesis Program, Academic Affairs Committee, 2010 - 2014
Member, GSBS Molecular Carcinogenesis Program, Student Admissions Committee, 2010 - 2013
Member, Department of Molecular Carcinogenesis, Hogg Seminar Series Committee, 2006 - 2012
Member, Department of Epigenetics and Molecular Carcinogenesis, Information Resources Advisory Committee, 2005
Member, Department of Molecular Carcinogenesis, Seminar Committee, 2003 - 2006
Member, Department of Epigenetics and Molecular Carcinogenesis, Tenure & Promotions Committee, 2001
Member, Department of Molecular Carcinogenesis, Library Committee, 1999 - 2010
Member, Department of Molecular Carcinogenesis, Cancer Genomics Committee, 1999
Member, GSBS Molecular Carcinogenesis Program, Admissions Committee, 1999 - 2002
Member, Department of Epigenetics and Molecular Carcinogenesis, Shared Resources Committee, 1998
Member, Department of Molecular Carcinogenesis, IACUC Committee, 1992 - 2005
Member, Department of Molecular Carcinogenesis, Faculty Search Committee, 1990 - 1994
Member, Department of Molecular Carcinogenesis, Graduate Education Committee, 1990 - 1999
Member, Department of Epigenetics and Molecular Carcinogenesis, Various Faculty Search Committees, 1989
Member, Department of Molecular Carcinogenesis, Postdoctoral Training Grant Committee, 1988 - 2001

Professor at University of Aveiro, Aveiro, Portugal

Assistant Professor, Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
Co-Chair, 2024 Translational Molecular Pathology Department Retreat, 2024 - 2024
Co-Chair, Translational Molecular Pathology Think Tank Seminar Series, 2022 - Present
Reviewer, Academic Review Committee, 2020 - Present
Co-Chair, Experimental Therapeutics Postdoctoral Seminars, 2017 - 2018
Honors & Awards
2019 The Thomas H. and Mayme P. Scott Fellowship in Cancer Research The Thomas H. and Mayme P. Scott Foundation, Inc, The Thomas H. and Mayme P. Scott Foundation, Inc
2018 AAAS/Science Program for Excellence, AAAS Science
2018 The Diane Denson Tobola Fellowship in Ovarian Cancer Research, The Diane Denson Tobola
2017 The Thomas H. and Mayme P. Scott Fellowship in Cancer Research, The Thomas H. and Mayme P. Scott Foundation, Inc
2015 Award in Translational/Clinical Research, Agilent
2014 Award in Translational Research, The Bayer HealthCare Pharmaceuticals, Inc
2012 AACR Scholar-In-Training Award, Susan G. Komen for the Cure

Dr. Irami Araújo Filho currently holds the position of Associate Professor II in the Discipline of Operative Technique within the Department of Surgery at the Federal University of Rio Grande do Norte. He is a Full Member of the Brazilian College of Surgeons and serves as Master of the Chapter of the Brazilian College of Surgeons in Rio Grande do Norte. Additionally, he is a Full Member of the Brazilian College of Digestive Surgery, a Member of the Pan American Trauma Society, and a Full Member of the Brazilian Society for the Development of Surgical Research.

He holds the role of Deputy Coordinator of the Research Base on Experimental Surgery at Clóvis Sarinho Teaching, Research Manager at Onofre Lopes University Hospital (HUOL), Federal University of Rio Grande do Norte, which is managed by the Brazilian Hospital Services Company - EBSERH. Dr. Araújo Filho is also a Preceptor of the HUOL General Surgery Medical Residency and Vice-President of the Regional of Rio Grande do Norte of the Brazilian Society for the Development of Surgical Research.

He serves as an Effective Professor in the Postgraduate Program in Biotechnology at Potiguar University and as an Effective Professor in the Graduate Program in Management and Technological Innovation in Health at UFRN/EBSERH.

Dr. Araújo Filho's professional experience spans various fields within Medicine, with a focus on General Surgery, Gastroenterology, and Oncology. His research interests include infection in surgery, intercurrent factors in wound healing, radionuclide biodistribution, and experimental models of osteoporosis.

Associate Professor, Faculty of Science, Biophotonics and Medical Imaging
Associate Professor, LaserLaB - Biophotonics and Microscopy

Professor, Federal University of Mato Grosso
Professor, Universidade Nove de Julho

Associate Professor of internal medicine, family medicine, and public health at Charles R. Drew University of Medicine and Science. 
Faculty Member with University of Michigan Psychiatry and UCLA Psychology.
With 20 years of research experience in public health, have published 500 peer-review manuscripts in journals archived by PubMed. Have served on the board of directors of the American College of Epidemiology (ACE) and American Academy of Health Behavior (AAHB). Was the past president of the Scientific Association for Public Health in Iran (SAPHIR).

Neurologist MD, MSc, PhD
Academic Scholar, Aristotle University of Thessaloniki

Adjunct Professor, Department of Psychiatry
Associate Chief of Staff Research and Development, VA Puget Sound

Professor, Departments of Pharmacology and Family & Preventive Medicine
PharmD, Purdue University
MBA, DePaul University
NHA, George Washington University

Associate Professor, Centre for Molecular Medicine and Biobanking, Allied Research Unit, Biomedical Building, University Of Malta

Research Scientist within the Center for Predictive Medicine at the University of Louisville

Professor (Assistant),  University of Bologna

Professor of Physiology Principal Investigator at Université de Poitiers- CNRS

Assistant Professor of the Department of Microbiology, Shahr-e-Qods Branch, Islamic Azad University

Roy G. Beran is trained as a consultant neurologist and accredited sleep physician, in addition to working within legal medicine, military medicine and aviation medicine.  His qualifications include: MBBS, MD, FRACP, FRACGP, Grad. Dip. Tertiary Ed., Grad. Dip. Further Ed., FAFPHM, FACLM, FRCP, FAAN, FACBS, B Leg. S, MHL and FFFLM (Hon). His Orcid ID is 0000-0002-5884-0606. He is registered with the Australian Health Practitioner Regulation Agency (AHPRA) as a specialist in Neurology, Public Health and Sleep Medicine and was a Designated Medical Examiner for the Civil Aviation Safety Authority, a medical assessor for Dispute Resolution for the State Insurance Regulatory Authority and an assessor for the Workers Compensation Commission of New South Wales (NSW). He is a Conjoint Professor of Medicine at the University of NSW; Professor in the School of Medicine at Griffith University, Queensland; and Professor, Chair, Medical Law, Sechenov Moscow 1st State University, Moscow, Russia.  Following Russia’s invasion of Ukraine, he refused to re-sign the agreement with Sechenov University. He was the inaugural Visiting Professor at the International Research Institute of Health Law Sciences at the Southern Medical University, Guangzhou, Guangdong Province, China. In 2022, he was appointed as a Conjoint Professor in the School of Medicine at the Western Sydney University, in addition to the above appointments.

Chief Executive Officer of Hôpitaux Robert Schuman

ESICM Basic Science Award, European Society for Intensive Care Medicine in 2012
Best Abstract Award, StO2 Shock Conference in 2009

Professor, Department of Physical Education and Aging Science, Universidade Sao Judas Tadeu, SP, Brazil

Professor, Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Director of the institute
Medical Specialist in Clinical Pharmacology
Medical Specialist in Pharmacology and Toxicology

Neuroradiologist

SB is Full Professor in Bioinorganic Chemistry at Leiden University. He obtained his PhD in 2005 at the University of Strasbourg, France, in the group of Nobel Laureate Jean-Pierre Sauvage, and moved to The Netherlands as a postdoc, where he successively worked in the groups of Gerard van Koten (Utrecht), Jan Reedijk (Leiden), and Antoinette Killian and Bert Klein Gebbink (Utrecht). Between 2009 and 2014 he completed a Tenure Track position in Inorganic Chemistry at Leiden University, where he was tenured in 2015. He obtained several prestigious grants, including a Starting Grant from the European Research Council (2013), and three young investigator grants (VENI 2008, VIDI 2012, VICI 2019) from the Dutch Organisation for Scientific Research (NWO). Since 2015 he is Fellow of the Young Academy of Europe, and in 2017 he became YAE Board Member. His expertise lies at the crossing point between bioinorganic chemistry, photochemistry, and lipid membranes. His current research interests are anticancer photoactivated chemotherapy, supramolecular photocatalysis, and upconversion.

Associate Professor of Gene Therapy, Tytgat Institute, AMC,Amsterdam

Degree in medicine and surgery at the University of Bologna (Italy), specialist license in General Surgery at the University of Modena (Italy) and in Implantology at the University of Sao Paulo (Brazil), Odont. Dr. (PhD) at Göteborg University (Sweden) with Prof. Jan Lindhe & Prof. Tord Berglundh.
Director of “Ariminum Research & Dental Education Center (ARDEC)” in Rimini, (Italy) and Head of the division of Oral Surgery at “ARDEC” (Ariminum Odontologica), Rimini (Italy).
Professor in the post-graduate course, University of the State of São Paulo (UNESP), Faculty of Araçatuba (Brazil). Invited professor at the University of Medical Science of Havana (Cuba) and at Valencia University (Spain).
Member of the Editorial Board of the Journal of Clinical Periodontology and of Clinical Oral Implants Research. He has published about 90 scientific articles on experimental and clinical studies in international scientific journals. He has held more than 400 lectures in courses and congresses in Italy, Europe, USA, South America, Asia, Africa.
His main fields of interest in research are healing of hard and soft tissues around implants and healing at implants installed in compromised sites.
He actively collaborates with Prof. Niklaus Lang in several clinical and experimental studies.
He collaborates in research with several universities.

Professor of Neurology, Chairman of the Department of Neurology, Faculty of Medicine, Masaryk University and St. Anne´s University Hospital, Brno, Czech Republic
Director of Brno Epilepsy Center
Research Group Leader of the Behavioral and Social Neuroscience Research Group CEITEC MU

Senior Medical Director, Clinical Development, Vertex Cell and Gene Therapies at Vertex Pharmaceuticals

1987 - Present : The First Affiliated Hospital, Nanjing Medical University ; 
1999 - Present : International Centre for Allergy Research, Nanjing Medical University  

Chief, The Six Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University

The Chief-Spine-Surgeon, Professor, Vice-president at the Affiliated Rehabilitation Hospital of Nanchang University, the Distinguished Professor of Orthopedics at the First Affiliated Hospital of Nanchang University, China. Serving as Asia Pacific Spine Society (APSS) Board Member, Scoliosis Research Society (SRS) Active Member, Cervical Spine Research Society (CSRS) Corresponding Member and Cervical Spine Research Society-Asia Pacific Section Active Member. Awarded for 2014 SRS GOP Fellowship (New York University Langone Medical Center, Johns Hopkins Hospital), 2015 CAOS-NASS Traveling Fellowship (UCSF, New York-Presbyterian Spine Hospital Columbia University Medical Center, MD Anderson Cancer Center), 2017 APSS Traveling Fellowship(National University Hospital of Singapore, Seoul St. Mary's Hospital Catholic University of Korea, Ganga Hospital of India), 2018 SRS Traveling Fellowship(Hospital for Special Surgery, New York-Presbyterian Spine Hospital Columbia University Medical Center, Washington University in St. Louis, TSRH, San Diego Rady Children's Hospital, Scripps Spine Center, San Diego Spine Foundation) and AO Spine Global Spine Diploma. Published more than 90 peer-reviewed papers focusing on Complex Spine Deformity, Osteoporosis, Cervical Spine, Spine TB.
Clinical services：Scoliosis, Kyphosis, Minimal invasive spine surgery, Spinal stenosis, Herniation, Ankylosing spondylitis, Spondylolysis, Spondylolisthesis, Cervical spine disorders, Cervical radiculopathy, Cervical myelopathy, Spine and spinal cord tumors, Spinal fractures, Revision spine surgery, Spinal osteoporosis,Degenerative spine disease, Spine tuberculosis, Spine trauma, Spine infection.

Dr. E. Carlos Rodriguez-Merchan is a highly accomplished consultant orthopedic surgeon currently working at Hospital Universitario La Paz in Madrid, Spain. With over three decades of experience in the field, Dr. E. Carlos Rodriguez-Merchan has established himself as a leading expert in orthopaedic surgery. He obtained his MD and PhD in orthopedic surgery from Hospital Universitario La Paz and has been actively practicing since 1990. Dr. E. Carlos Rodriguez-Merchan is renowned for his exceptional skills and expertise in performing various orthopaedic procedures. He has made significant contributions to the field through his research and publications.

Associate Professor of Surgery, University of Bologna
Chief General and Emergency Surgery, Bufalini Hospital AUSL Romagna, Italy

Dr. William Cho is a biomedical scientist at the Department of Clinical Oncology, Queen Elizabeth Hospital in Hong Kong. With a strong background in cancer biomarker discovery and translational research, Dr. Cho has published extensively in peer-reviewed journals. His research interests include genomics, proteomics, and liquid biopsy in oncology. He actively serves on editorial boards and is a frequent reviewer for international scientific journals.

Dean of the Faculty of Dentistry at the University of Otago in New Zealand. Paul was appointed the John Arnaud Bell Professor of Oral Biology in 2019 at the University of Otago and previously, he worked at the School of Dentistry, University of Birmingham, UK (2000-2019), where he was the Director of Research and Deputy Head of School. Paul has published over 180 full peer-reviewed papers in several areas of dental research with particular interest in pulp biology. In 2010, Paul was awarded the IADR Distinguished Scientist Young Investigator Award. He is currently the President of the Pulp Biology and Regeneration Group of IADR and has also served as the Mineralized Tissue Group (MINTIG) Chair for the British Society for Oral and Dental Research (BSODR) and as a counselor on the BSODR Management Committee.

Assistant Professor, Emergency Medicine, Università Cattolica del Sacro Cuore, Rome, Italy

Research Assistant, Department of Pathology, Medical University of South Carolina (1990)

·  Teaching of Emergency Medicine (2009 – 2015) medical specialization schools: Allergologia ed Immunologia Clinica – Dermatologia e Venereologia – Ematologia – Endocrinologia e malattie del ricambio – Gastroenterologia – Geriatria – Malattie dell’apparato Cardiovascolare – Malattie dell’apparato respiratorio – Malattie infettive – Malattie Tropicali – Medicina interna – Neurofisiopatologia – Neurologia – Oncologia – Psichiatria – Reumatologia - Catholic University of the Sacred Heart - Rome
·   Teaching of Emergency Medicine 2012 – present: School of Specialization in Emergency Medicine  Catholic University of the Sacred Heart - Rome
·   Teaching of Emergency Medicine and First Aid response 2012 – Present: School of specialization in Sport Medicine and School of Internal Medicine - Catholic University of the Sacred Heart – Rome
·   Assistant Professor – Emergency Medicine - Catholic University of the Sacred Heart – Rome 2020 - Present
·   Author of 111 papers published on peer-reviewed journals from 1993 to present (H-index Scopus 23)
·   Author of more than 300 Abstracts presented in National and International Meetings.
·   Member of Italian Society of Emergency Medicine (SIMEU)
·   Member of Italian Society of Internal Medicine (SIMI)Assistant Professor, Emergency Medicine, Università Cattolica del Sacro Cuore, Rome, Italy

Linda Cox, MD, FAAAAI is an allergist in solo private practice in Ft Lauderdale and a clinical associate professor of medicine at Nova Southeastern University. She is a member of the American Academy of Allergy Asthma & Immunology’s (AAAAI) board of directors, and begin her term as AAAAI President on February 25, 2013.

She is past chair of many committees including the AAAAI Immunotherapy, Allergen Standardization and Allergy Diagnostics Committee (IT/AD/ST) and the Immunotherapy, Rhinitis, Sinusitis, Ocular diseases & Cough Interest Section. She has chaired several AAAAI/ACAAI joint task forces including the Sublingual Immunotherapy Joint Task Force, Specific-IgE test Task Force (SETTaF), and the Omalizumab Joint Task Force.

Since 2006, Dr. Cox has been a member of the Joint Task Force on Practice Parameters (JTPP), and was one of the chief editors of the 2^nd and 3^rd updates of the Allergen Immunotherapy: A Practice Parameter.  She has promoted standardization of allergy skin testing and allergen immunotherapy practice through work of the JTFPP and IT/AD/ST. which resulted in the development of standardized immunotherapy, skin test, instruction and consent forms, available at www.aaaai.org.  

Through the World Allergy Organization (WAO), she assisted in the development of a uniform grading system for subcutaneous immunotherapy systemic reactions. She is current co-chair of the WAO Immunotherapy and Immunomodulator Committee.

Dr. Cox is a member of the American Board of Allergy and Immunology Board of Directors, and serves on several of its committees including the Maintenance of Certification and Conjoint Standards committees. She is a past president of the Broward County Medical Association and the Florida Allergy, Asthma & Immunology Society. She was a member of the Florida Medical Association Board of Governors. She has been a member of the BCMA Board of Directors since 1995 She has served as a BCMA delegate almost since almost every year since joining the BCMA and is immediate past chair of the South Florida Caucus Advisory Council.

Dr. Cox attended medical school at Northwestern University in Chicago and completed her fellowship in allergy and immunology at National Jewish Center in Colorado.

Awards/Honors

Dr. Cox has been honored nationally with many awards including: the 2012 AAAAI Women’s Involvement Special Recognition Award; the AAAAI President’s Award for Outstanding Leadership (as Chair of the Immunotherapy and Allergy Diagnostics Committee); an ACAAI Distinguished Service Award and the ACAAI Woman in Allergy Award. Regionally, she received and the Florida Academy of Physician Assistants 2010 Physician Recognition Award.

Dr Undurti N Das, MD, DSc, FAMS, FRSC Prof. Undurti N Das is a physician/scientist based both in the USA and India. His clinical interests include internal medicine with an emphasis on diabetology, endocrinology, rheumatology, and cancer. His research interests include polyunsaturated fatty acids, cytokines, free radicals, and their role in various diseases. Dr. Das is an M.D. in Internal Medicine from India, a DSc in biotechnology, a fellow of the National Academy of Medical Sciences (New Delhi), and a Fellow of the Royal Society of Chemistry, London. He is the recipient of the Shanti Swaroop Bhatnanagr prize in Medical Sciences, the highest scientific award in India. He has published more than 500 original research papers, authored four books, and currently is the Founding Editor of the Lipids in Health and Disease journal by BioMed Central, UK; Review Editor of Nutrition by Elsevier; and Academic Editor of Medicine. He is the President and CEO of UND Life Sciences of USA and Professor and Director of the BioScience Research Centre and Department of Medicine, GVP Medical College and Hospital, Visakhapatnam.

Professor,Departments of Social and Behavioral Sciences and Epidemiology, School of Global Public Health, New York University
Honors/Awards
Ranked in top 5% of investigators for receipt of NIH funding over the past 25 years
ISI identified ―Highly Cited Author‖
Visiting Distinguished Professor, Department of Psychology, University of Spain,
Granada, July 2007.
Prevention Pioneer Award in HIV/AIDS from the Morehouse School of Medicine and the Georgia
Department of Community Health, Office of Minority Health, February 24, 2005
McAuley Lecture for 2003, Georgetown University, November 3, 2003.
Great Teachers Lecture, February 17, 2000, Emory University
Recipient of the 1999 Society for Adolescent Medicine/Organon Pharmaceutical Visiting
Professorship in Adolescent Research
Ira Hiscock Lecturer for 1996. The University of Hawaii, School of Public Health, Oahu, HI,
October 29, 1996
Robert S. Rixse Memorial Lecturer for 1996. Children's National Medical Center, Washington, DC,
June 4, 1996
Kroeber Anthropological Society Plenary Address, March 7, 1987, University of California,
Berkeley, CA 

PhD, EDIC, Chief Director, Cardiac Surgery ICU at Onassis Hospital

Director Cardiac Surgery ICU, Onassis Cardiac Surgery Center
Medical Internist-Intensivist
Co-Director, ECMO referral Center (ELSO)

Associate Professor and biostatistician at The George Washington University School of Nursing
Associate Scientist in the Department of Biostatistics & Medical Informatics and co-director of the Biostatistics and Data Management Unit at the Wisconsin Alzheimer's Disease Research Center (ADRC)

Professor, College of Medicine and Life Sciences, University of Toledo 

2018, Jan-present Associate Professor in pharmacology and therapeutics)  Sapienza University of Rome, Department of Physiology and Pharmacology "Vittorio Erspamer" Rome, Italy
2008-2017 (December) Assistant professor (University Researcher ) in Toxicology  / Clinical trials , pharmacoepidemiology and pharmacovigilance
2012-2013 (January-April) Visiting assistant professor at Beth Israel Deaconess Medical Center, Department of  Neurology Boston, United States
2010 Lecturer of Clinical trials , pharmacoepidemiology and pharmacovigilance
2008 Researcher (Assistant Professor in pharmacology and therapeutics)  Sapienza University of Rome, Department of Physiology and Pharmacology "Vittorio Erspamer" Rome, Italy

MD, doctor of ultrasound in the Department of Peking University Third Hospital. Graduated from Peking University, majoring in imaging medicine and nuclear medicine. Main research interests are: Ultrasound diagnosis and interventional therapy, contrast-enhanced ultrasound and elastography.

Dr Carmine Finelli is currently senior registrar of the Department of Emergency and Internal Medicine, Ospedale S. Maria della Pietà – ASL Napoli 3 Sud, Nola (Naples), Italy. Dr. Finelli obtained his Doctor of Medicine degree in 1999 at the Federico II University Medical School in Naples discussing the thesis: “Prevalence of eating disorders in obese outpatients”. He obtained his PhD in “Clinic and Pathology of Chronic-Degenerative Cardiovascular, Rheumatic and Nutritional diseases” at the Department of Clinical and Experimental Medicine, Federico II University Medical School in Naples in 2004.  Research work was carried at the Clinical Nutrition Unit of the same Department. He also obtained his postgraduate degree in Internal Medicine, in 2008, at the Department of Clinical and Experimental Medicine, Federico II University Medical School in Naples. His main research interests are in polymorphism genetic in severe obesity; indicators of the nutritional status; pathogenetic mechanisms of insulin-resistance, hypertension and fatty liver in obesity; physical activity and energy expenditure in human obesity; metabolic and nutritional status in severely obese patients treated with bariatric surgery at short and long-term. He is also author of more than 124 papers, 46 published on peer-reviewed international journals. Dr. Finelli is currently involved in studies on the physiopathology, genetic and treatment of obesity. 

Dr Carmine Finelli is currently senior registrar of the Department of Emergency and Internal Medicine, Ospedale S. Maria della Pietà – ASL Napoli 3 Sud, Nola (Naples), Italy. Dr. Finelli obtained his Doctor of Medicine degree in 1999 at the Federico II University Medical School in Naples discussing the thesis: “Prevalence of eating disorders in obese outpatients”. He obtained his PhD in “Clinic and Pathology of Chronic-Degenerative Cardiovascular, Rheumatic and Nutritional diseases” at the Department of Clinical and Experimental Medicine, Federico II University Medical School in Naples in 2004.  Research work was carried at the Clinical Nutrition Unit of the same Department. He also obtained his postgraduate degree in Internal Medicine, in 2008, at the Department of Clinical and Experimental Medicine, Federico II University Medical School in Naples. His main research interests are in polymorphism genetic in severe obesity; indicators of the nutritional status; pathogenetic mechanisms of insulin-resistance, hypertension and fatty liver in obesity; physical activity and energy expenditure in human obesity; metabolic and nutritional status in severely obese patients treated with bariatric surgery at short and long-term. He is also author of more than 124 papers, 46 published on peer-reviewed international journals. Dr. Finelli is currently involved in studies on the physiopathology, genetic and treatment of obesity. 

Marco Fiore is a Researcher at IBBC-CNR—Institute of Biochemistry and Cell Biology-CNR. He completed his Ph.D. studies in Medical Sciences at the University of Groningen in 2004. He has published 39 papers, with 5900 citations and an h-index of 50 (Scopus, october 2024). His research topics mainly include oxidative stress, neurobiology, toxicology, and addiction.

 Executive Chairman of the Board, Can-Fite BioPharma, Petah Tiqwa, Israel

Prof. dr Sandrine Florquin, Renal Pathologist, P.I., Department of Pathology, Academic Medical Center, University of Amsterdam 

Prof. Dr. Eleonore Fröhlich is the Head of Core Facility Microscopy at the Center for Medical Research, Medical University of Graz, Graz, Austria. Besides, she is also a key researcher at the Research Center of Pharmaceutical Engineering, a professor at the Institute of Anatomy, University Tübingen, and a mentor at NORGANOID GmbH. She was awarded the Top 2% cited scientist (field pharmacology and pharmacy), Stanford University Ranking in 2022, and Testing of inhaled nanoparticles in airway tissues (1st prize) in 2021. Her scientific expertise is in histology, microscopy, electron microscopy, cell culture, immunohistochemistry, nanotoxicology, cell-based assays, and inhalation.

MD, PhD, Professor, Molecular pathologist, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Visiting Professor of Haematology, Imperial College London
Honorary Professor, Institute of Hematology, Chinese Academy of Medical Sciences and Peking Union Medical College
Fellow, American College of Physicians
Fellow, Royal College of Physicians; Fellow, Royal Society of Medicine; Fellow, Royal College of Physicians of Ireland
Honorary Member, Russian Academy of Medical Science
Olender Peace Award, 1986 and 2017
Presidential Award, New York Academy of Science, 1986
Scientist of Distinction Award, Weizmann Institute of Science, 1986
Editorial Board of 12 journals, including Editor-in-Chief, Leukemia; Executive Editor, Bone Marrow Transplantation; Associate Editor, Clinical Transplantation
Over 1300 scientific articles and more than 20 books

Professor, Surgery Turku University Hospital, University of Turku, Turku, Finland

Senior Research Specialist, Department of Laboratory Medicine, Karolinska Institutet 

Post-Doc, Sapienza University of Roma 

Prof. Zhongwei Gu is a Professor at the West China Hospital of Sichuan University. Prof Gu has been appointed as a Chief Scientist of the National Basic Research Program of China (the 973 Program)for three five-year periods since 1999. He has awarded awards NIiETOUS including the Fellow of the International Union of Societies for Biomaterials Science and Engineering(FBSE) and the Distinguished Visiting Fellow ship Awand of the Royal Academy of Engineering. He has ublished over 300 peer-reviewed scientific manuscripts and held ore than 30 issued patents, His research activities focus on anobiomaterials,biomimetic deliverysystems,and tissue engineering.

Director of Unit of Radiation Oncology, Ospedale del Mare, Naples, Italy

Dr. Merete Haedersdal is a dermatologist and associate clinical professor of dermatology at the University of Copenhagen, Denmark. She directs the Laser Dermatology Clinic at Bispebjerg University Hospital in Copenhagen. Currently Dr. Haedersdal is a visiting associate professor at the Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School focusing on “laser-assisted drug delivery” together with Dr. R. Rox Anderson’s team.She received her M.D. degree from the Medical School program of the university of Copenhagen, Denmark and she was authorised as a specialist in dermato-venereology in 2004. Dr. Haedersdal received her Ph.D degree in 1997 and became Dr. of Medical Science in 1999 from university of Copenhagen. Her theses cover different aspects of side effects from dermatological laser procedures in murine and human experiments. Dr. Haedersdal is consultant for the National Board of Health in Denmark and she has actively been involved in the Danish legislation about safety in aesthetic procedures with lasers, IPL systems and related technologies. Her research interests include laser therapy in dermatology, photodynamic therapy, skin cancer, and evidence-based treatments with light-emitting devices.

Prof. Michael Hamblinwas the Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. He was trained as a synthetic organic chemist and received his PhD from Trent University in England. His research interests lie in the areas of photodynamic therapy (PDT) for infections, cancer, and heart disease and photobiomodulation for wound healing, arthritis, traumatic brain injury and hair regrowth. He directed a laboratory of sixteen post-doctoral fellows, visiting scientists and graduate students. His research program is supported by NIH, CDMRP, USAFOSR and CIMIT among other funding agencies. He has published over 600 peer-reviewed articles, over 150 conference proceedings, book chapters and international abstracts and holds 8 patents. He has authored/edited 23 textbooks on PDT and photomedicine including SPIE proceedings. He is Associate Editor for 10 journals, on the editorial board of a further 25 journals and serves on NIH Study Sections. For the past 10 years Prof Hamblin has chaired an annual conference at SPIE Photonics West entitled “Mechanisms for low level light therapy” and he has edited the 10 proceedings volumes together with four other major textbooks on PDT and photomedicine. He has several other book projects in progress at various stages of completion. Prof Hamblin has received a number of prestigious honours and awards, and in 2011 was honored by election as a Fellow of SPIE. Prof Hamblin has been appointed as a visiting professor at a number of institutions including the Guangxi Medical University, Nanning, China, Laser Research Centre Health Sciences, University of Johannesburg, South Africa, and School of Pharmacy, University of Ulster Coleraine, UK. Prof Michael Hamblin is the world’s the most documented authority on Neuromodulation. He is Editor-in-Chief of “Photobiomodulation, Photomedicine and Laser Surgery”, is Associate Editor for 10 other journals. He has a Scopus H-index of 104 with 44918 citations. He has been on the Clarivate Web of Science list of most highly cited authors for the last 3 years. Dr Hamblin was elected as a Fellow of SPIE in 2011, received 1st Endre Mester Lifetime Achievement Award Photomedicine from NAALT in 2017, and Outstanding Career Award from Dose Response Society in 2018.

Dr. Jinming Han is a neurologist at Xuanwu Hospital, Capital Medical University, Beijing, China. Dr. Han obtained an MSc in neurology from Jilin University, China and a PhD from Karolinska Institutet, Sweden. His research interest focuses on exploring novel immunotherapies for neuroinflammatory diseases such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) using big data. Dr. Han’s research topics also include colony stimulating factor 1 receptor (CSF1R)-related leukoencephalopathy and whole-genome sequencing, carrying out a strongly linked research program aimed at applying updated knowledge from experimental studies to clinical situations. Dr. Han has published over 60 scientific papers and reviewed over 600 scientific papers. He has wide experience with editing scientific papers and managing critical decisions.

Prof. Dr. Alireza Heidari, Ph.D., D.Sc.
Full Distinguished Professor and Academic Tenure of Chemistry 
Enrico Fermi Distinguished Chair in Molecular Spectroscopy
Head of Cancer Research Institute (CRI) 
Director of the BioSpectroscopy Core Research Laboratory (BCRL)
Faculty of Chemistry, California South University (CSU), Irvine, California, USA 
Board Member of the World Association of Theoretical and Computational Chemists (WATOC) 
Continuous Member of the American Association for Cancer Research (AACR), Philadelphia, Pennsylvania, USA 
Continuous Member of the American Society for Biochemistry and Molecular Biology (ASBMB), Rockville, Maryland, USA 
President of the American International Standards Institute (AISI), Irvine, California, USA 

Sen Post Doc · Medical University of Innsbruck, Dept. for Anesthesia and general intensive Care

Adjunct Professor, Department of Obstetrics and Gynecology, McGill University   
Medical Director of the McGill University Health Centre (MUHC) Reproductive Centre
Director of the Reproductive Endocrinology and Infertility Division of McGill University in Montreal 
Director of the R.E.I. and I.V.F. Departments
Associate Director of the Division of Obstetrics and Gynecology, at the Hadassah Medical Organization in Israel
Member of provincial ART advisory committees in both Quebec and Ontario

Shareholder & Owner, Innovation Center for Advanced Technology, Matrix HT, Inc. New York, USA

2024.08- Director, School of Nutrition and Health Sciences, Taipei Medical University
2023.07 – 2023.09 Acting Chair, School of Nutrition and Health Sciences, Taipei Medical University
2023.07 – 2023.09 Acting Vice Dean, College of Nutrition, Taipei Medical University
2017- Professor, School of Food Safety, Taipei Medical University
2017- Professor, Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University
2017- Professor, School of Nutrition and Health Sciences, Taipei Medical University
2013-2017 Associate Professor, School of Nutrition and Health Sciences, Taipei Medical University
2012-2013 Assistant Professor, School of Nutrition and Health Sciences, Taipei Medical University
2012-2012 Associate Professor, Kai-Nan University
2009-2012 Assistant Professor, Kai-Nan University
2007-2009 Assistant Professor, Cardinal Tien College of Healthcare and Management
2006-2007 Postdoctoral researcher, National Taiwan University
Awards
2024 Research Dissertation Award - Excellence Award, Taipei Medical University
2019 Research Dissertation Award - Excellence Award, Taipei Medical University
2019 International Top Journal Publication Award, Taipei Medical University

Professor of ophthalmology at New York Medical College and the Icahn School of Medicine at Mount Sinai, as well as the director of the Organ Culture Center at New York Eye and Ear Infirmary.
Hu attended and graduated from the Medical Department of Shanghai First Medical College from 1952 to 1955. After graduation, Hu worked at several institutions including Second Hospital of Shanghai Textile Engineering Bureau, Shanghai Branch of the Chinese Medical Association. In 1979, he became the director of the Zhabei Eye Disease Prevention and Control Institute in Shanghai, holding the position of deputy chief physician.
Hu has served as a research consultant for pharmaceutical companies such as Pfizer, Merck, and Allergan, etc.
Hu major research achievements include the establishment of methods for the isolation and culture of choroidal and conjunctival melanocytes, and iris pigment epithelial cells, as well as the establishment of an eye cell bank. He conducted research on the etiology, epidemiology, and drug treatment of ocular melanoma, and resolved the long-standing debate on the relationship between ocular melanoma and sunlight. He also conducted research on the etiology, pathogenesis, genetics, and epigenetic regulations of myopia and age-related macular degeneration.
In the field of translational medicine, Hu conducted studies on the transplantation of cultured skin melanocytes for the treatment of vitiligo, oral retinoid acid therapy for proliferative vitreoretinopathy, and transplantation of iris pigment epithelial cells for the treatment of retinal diseases.
He has published over 300 papers, including 147 in SCI journals such as Am J Human Genet, Cancer Res, Pigment Cell Melanoma Res, J Med Genet, Ophthalmology, JAMA Ophthalmology, Am J Ophthalmol, Invest Ophthalmol Vis Sci, J Am Acad Dermatol, and Br J Dermatol. He has authored several books on ophthalmic genetics and myopia, and co-authored nine international ophthalmology monographs.
Hu has received numerous research grants and awards, including the 2009 National Science and Technology Progress Award (Second Prize) for clinical research and application of simple myopia prevention. He was also awarded the Outstanding Achievement Award in Ophthalmology and Visual Science for Overseas Chinese by the Chinese Medical Association's Ophthalmology Branch.
He organized the Chinese Genetic Society's Ophthalmic Genetics Group and served as its chairman from 1979 to 1989. He was also involved in the establishment of the Chinese Ophthalmological Society's Ocular Optics Group and served as its executive vice chairman in charge of academics. He organized and chaired 11 international academic conferences on ocular melanocytes and myopia.
Hu has been invited to give academic lectures at institutions such as the National Eye Institute, Harvard University, and Yale University.
He has served as an executive director of the International Society of Ophthalmic Genetics, president of the International Society for Ocular Melanocyte Research, Association.
He has also served as editor-in-chief and editorial board member of several academic journals, including deputy editor-in-chief of Pigment Cell Research and reviewer for important journals such as Proc Natl Acad Sci USA and Ophthalmology.

Professor Can Ince is a physiologist at the at the Academic Medical Center (AMC), University of Amsterdam and Erasmus Medical Center (EMC), Erasmus University Rotterdam, The Netherlands. His chair in Clinical Physiology at the AMC is dedicated to cardiovascular aspects of surgery and intensive care focused on clinical and fundamental aspects of circulation and oxygenation. He heads the Department of Translational Physiology at the AMC. The Department consists of a group of basic and clinical scientist doing laboratory and clinical research in sepsis, shock, resuscitation, fluid therapy, blood transfusion, oxygen transport, microcirculation, mitochondria, acute kidney injury and heart failure. In addition medical technology research related to the afore mentioned topics is carried out. Since 2007 , he joined for 40% the Department of Intensive Care of the Erasmus Medical Center Rotterdam (prof Jan Bakker) where he also works in collaboration with the Dept of Pediatric and Neonatal Intensive Care of the Sophia Children’s Hospital (Prof Tibboel and Prof Reis). This combination allows bench to bedside translation of concepts, diagnostic and therapeutic modalities related to circulation and oxygenation. He holds a PhD in Immunology/ Physiology and has a MSc and BSc in Electrical and Electronic Engineering. Prof Ince is past-president of the Dutch Physiological Society and past-president of the International Society of Oxygen Transport to Tissue. He has an H-index of 43, has authored over 300 peer reviewed papers and holds patents related to microcirculation technology.

Dr. Marcello Iriti is an Associate Professor of Plant Biology and Pathology within the Department of Agricultural and Environmental Sciences at the University of Milan.

He has been studying nutraceuticals, functional foods, phytotherapeutics and essential oils relevant for human and animal health, focusing on their preclinical (in vitro/in vivo) and in human pharmacological activities. He has also been investigating the health-promoting effects of traditional Mediterranean diet as well as the ethnopharmacology of herbal remedies of traditional healing systems.

Dr. Iriti is a Member of the World Academy of Sciences, Asian Council of Science Editors and Society of African Journal Editors. Founding Member of the Italian Society of Environmental Medicine. Member of the Working Group ‘Pharmacognosy, Phytotherapy and Nutraceuticals’ of the Italian Pharmacological Society.

Associate Professor of periodontology and oral medicine at the School of Dentistry, University of Catania, Italy
Member of the Italian Society of Oral Surgery (SIdCO)
Member of the International Association of Dental Research (IADR) 
Member of the Italian Society of Periodontology (SIdP)

Associate Professor (Sungkyunkwan University, 2023-present)
Assistant Professor (Sungkyunkwan University, 2019-2023)
Postdoctoral Scholar (Stanford University, 2015-2018)
Graduate Researcher (Nanyang Technological University, 2011-2015)
Graduate Researcher (Harvard-MIT, 2010-2011)
Undergraduate Researcher (Stanford University, 2008-2010)
Undergraduate Researcher (University of Florida, 2007-2008)

Professor in the Department of Surgery and the Department of Biochemistry and Biomedical Sciences at McMaster University, and he also holds a professorship at the University of Toronto. Dr. Jeschke’s research focuses on uncovering the challenges that older adult burn patients face and understanding why they often experience poorer outcomes. His work examines how severe burn injuries accelerate biological aging processes by impacting tissue plasticity, immune function, and metabolic resilience. Through studying these age-related declines and the cellular and molecular changes that contribute to them, Dr. Jeschke aims to identify therapeutic targets to enhance recovery and counter the accelerated aging observed in trauma survivors.

Professor in Ophthalmology and Bioengineering Hanna and Mark Gleiberman Chancellor's Endowed Chair in Glaucoma Research

Professor, College of Medicine, Medical University of South Carolina, Charleston, USA

Professor Emeritus, Department of Cardiology, University of Patras Medical School Patras, Greece
Scientific Advisor, Patras State General Hospital, Patras, Greece
Practicing Cardiologist

Head of Hepatology at the Department of Gastroenterology and Hepatology, University Hospital Zurich in Zurich, Switzerland. Professor Kremer is internationally recognized as a clinician, educator and researcher in liver disease. His translational, clinical and experimental research is focused on molecular mechanisms of immune-mediated and cholestatic liver disease including symptom burden such as fatigue and pruritus, fibrogenesis and development of hepatocellular carcinoma. Prof. Kremer has been awarded several national and international research prizes including the Schering-Plough of the Dutch Society of Gastroenterology. His scholarly work has been cited more than 6,500 times (h-index: 42), according to Google Scholar, and he is a member of editorial boards for various journals. He served as a chair for several national and international guidelines, is a member of the Board of Directors of the Swiss Association for the Study of the Liver (SASL) and Chair of International Forum for the Study of Itch special interest group for systemic pruritus.

Professor, Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria

Assistant professor, Erasmus University Medical Center

Assistant Professor, Department of Human Genetics, Emory University, Atlanta, USA

Professor, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China

Professor, The Second Affiliated Hospital of Nanchang University
Chief physician, The Second Affiliated Hospital of Nanchang University

Professor, Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing, China
Dircector, Chinese PLA General Hospital (301 Hospital)

Giuseppe Lanza, MD PhD, is Full Professor of Advanced Medical and Surgical Technical Sciences at the University of Catania (Italy). He further trained at the Department of Neuroscience and Clinical Neurophysiology of the Newcastle University (UK) as Visiting Clinical Research Fellow, where he was also selected for a Scientific Fellowship promoted by the European Federation of Neurological Societies. From 2013, he has been working as Consultant Neurologist and Chief of the Clinical Neurophysiology Research Unit at the Oasi Research Institute-IRCCS in Troina (Italy), a WHO collaborating Center for Neurosciences. More recently, Prof. Lanza obtained the Master of Science in Clinical Research and in Neurorehabilitation, as well as the international “Elio Lugaresi Award” by the World Sleep Society. He authored >200 publications in international peer-reviewed Journals and has given talks at numerous Conferences/Meetings. Current h-index is 47 (Scopus), along with >5,200 citations. Clinical-research interests include: clinical neurophysiology, neurosonology, non-invasive brain stimulation, and neuroplasticity. 

Herb and Jean Lyman Centennial Chair in Ophthalmology, Department of Ophthalmology-Blanton Eye Institute
Professor of Ophthalmology, Neurology, and Neurosurgery, Academic Institute
Member, Research Institute, Academic Institute
Chair, Department of Ophthalmology-Blanton Eye Institute
Program Director, Neuro-Ophthalmology Fellowship, Department of Ophthalmology-Blanton Eye Institute

Chair of Department of Pathology, Chi Mei Medical Center
Professor at Southern Taiwan University of Science and Technology
Joint-appointment associate investigator at National Institute of Cancer Research (Taiwan)

Prof. Dr. Jian-Jun Li is a renowned cardiologist at Fu Wai Hospital, Chinese Academy of Medical Science, Beijing. He holds an MD from Wuhan University, a PhD from Kyushu University, Japan, and completed post-doctoral training in the USA. As Professor and Consultant at the Cardiometabolic Center, his research focuses on dyslipidemia, inflammation, atherosclerosis, and interventional cardiology. He serves as Vice President of the Chinese Molecular College of Cardiology and is a national expert in cardiovascular disease prevention. Prof. Li has received multiple prestigious science awards, recognizing his significant contributions to cardiovascular medicine and public health in China.

Associate Professor in Department of Neurological Surgery at Rush University, Chicago, USA. He has a number of research interests, and his brain tumor work is largely focused on the development of a DNA vaccine for treatment of primary and metastatic intracerebral tumors. In particular Dr. Lichtor has shown that vaccines prepared by transfer of DNA from the tumor into a highly immunogenic cell line stimulates an antitumor immune response which may be efficacious in the treatment of patients with brain tumors. Other research interests include developing a passive immunotherapeutic strategy for treatment of Alzheimer’s Disease. In addition, he has been involved in the development of a non-invasive MRI technique to measure intracranial pressure and brain compliance, and has been exploring the efficacy of this modality in managing a variety of patients with neurologic problems where intracranial pressure is an issue. Dr. Lichtor is a member of the neurosurgery faculty at Rush University Medical Center in Chicago, Illinois.

Ton Lisman is a biochemist with a profound interest in translational clinical research. He received his PhD at the Department of Hematology from the University Medical Center Utrecht in The Netherlands on a thesis on the mechanism of action of recombinant coagulation factor VIIa in 2002. Since 2007, he works at the Surgical Research Laboratory and the Section of Hepatobiliary Surgery and Liver Transplantation at the Department of Surgery of the University of Groningen in The Netherlands. He was appointed full professor of Experimental Surgery in 2015. He serves as co-Editor in Chief for the Journal of Thrombosis and Hemostasis and leads the ISTH/SSC subcommittee on “Hemostatic management of patients with liver diseases”. His research interests include hemostatic changes in liver disease and liver surgery, the role of hemostatic components in damage and repair of liver tissue, and the role of the fibrinolytic system in thrombosis. These topics are studied in close collaboration with local and international clinical partners, which include surgeons, hepatologists, hematologists, intensivists, and anethesiologists.

Professor in the Department of Microbiology, Immunology and Biopharmaceuticals at National Chiayi University, Taiwan

Professor, Department of Paediatrics, Willem-Alexander Children’s Hospital, Leiden University Medical Center
Head, Department of Paediatrics, Willem-Alexander Children’s Hospital, Leiden University Medical Center

Professor,  Institute of Pharmaceutics, School of Pharmaceutical science, Shandong University

Raimundas Lunevicius, MD, PhD, DSc, FRCS, Professor, is a Consultant in Emergency General and Trauma Surgery at Aintree Hospital, NHS University Hospitals of Liverpool Group, UK, with extensive experience in biliary, gastrointestinal, abdominal wall, visceral trauma surgery, research, clinical audits, education, supervision, medical appraisal, academic editing, and review. He has completed three fellowship programmes: Monbushou (Nagoya University & Aichi Cancer Centre, Japan, 1998–2000), Fulbright–Humphrey (Johns Hopkins University, Bloomberg School of Public Health, US, 2008–2009), and King’s College Hospital (2010–2012). His publications (h-index 78) include 263 refereed articles (PubMed 167), three monographs, seven book chapters, and three edited books (by 15–06–2025). He is the Editor-in-Chief of ‘Emergency Care and Medicine’ (MDPI, Switzerland) and a senior GBD Network collaborator (USA).

Recipient of the National Science Fund for Distinguished Young Scholars
Second-level professor at the School of Medicine, Shanghai Jiao Tong University
Executive director of Gastroenterology and director of Infectious Diseases at Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Deputy director of Shanghai Institute of Digestive Disease
Member of the International Autoimmune Hepatitis Group
Member of the Global Primary Biliary Cholangitis Organization
Member and deputy secretary-general of the Liver Diseases Branch of the Chinese Medical Association
Standing member of the Liver Diseases Professional Committee of the Chinese Research Hospital Association
Deputy chairman of the Liver Diseases Specialty Committee of Shanghai Medical Association
Expert member of the Quality Control Center for Infectious Diseases in Shanghai
Member of the Infectious Diseases Branch of Shanghai Association of Chinese Medicine
Member of the Shanghai Clinical Research Academic Committee, editor-in-chief of International Journal Of Cardiovascular Disease
Deputy editor-in-chief of Gastroenterology
Deputy editor-in-chief of the international academic journal Journal of Gastroenterology & Hepatology.

Head of Department of Histology and Embryology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

Marc Maresca, Ph.D.
Research Director
Institute of Molecular Sciences of Marseille (iSm2), CNRS
Aix-Marseille University, Marseille, France

Dr. Georgios Antonios Margonis is a senior scientist affiliated with the Department of Surgery at the Memorial Sloan Kettering Cancer Center (MSKCC) and the Operations Research Center of the Massachusetts Institute of Technology (MIT). He earned his MD and PhD degrees from the University of Athens before relocating to the United States in 2014. Since then, he has held positions at Harvard University and the Johns Hopkins University before joining MSKCC. His clinical and research interests encompass hepato–pancreato–biliary diseases and soft tissue sarcomas, with a particular focus on the utilization of biomarkers to inform surgical or medical interventions. More recently, his research has delved into the intersection of artificial intelligence and oncology. Dr. Margonis has authored or co-authored more than 170 papers and has received several national and international awards. Notable awards he has received include the IHPBA Kenneth Warren Award and the Johns Hopkins University Paul Ehrlich Award for outstanding research achievements. He also serves as a reviewer for over 70 journals including The Lancet, JAMA, and Annals of Surgery.

Dr. Martinez-Sobrido is continuing his work with the New York Influenza Center of Excellence, which is part of the National Institute of Allergy and Infectious Diseases Centers of Excellence for Influenza Research and Surveillance (CEIRS) program through the National Institutes of Health. In addition to characterizing the influenza virus, as part of this project, he is working with collaborators to develop a universal flu vaccine with the use of broadly neutralizing antibodies (bNAbs) or blood proteins that can recognize key pieces of the virus to help a person’s immune system clear infected cells from the system. Studies are underway to test these bNAbs in small animal models and suitable candidates will move into nonhuman primate models.

Associate Professor, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Professor, Department of Physiotherapy, University of Valencia, Valencia, Spain

Professor, Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba
Scientist, Children's Hospital Research Institute of Manitoba

Professor of Gastroenterology at the University of Leicester 
Director of the Leicester Complementary Therapy Centre. 

Professor of Pathology, Microbiology and Immunology, School of Medicine, Vanderbilt University, Nashville, USA

Professor of Musculoskeletal Biology in the Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Finland
Chief Researcher and International Adviser at the State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
Previously President of the Osteoarthritis Research Society International (OARSI)
Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Scientific Collaborator at the Université de Liège
Active member of OARSI and the International Cartilage Regeneration & Joint Preservation Society (ICRS), serves on the Translational Science Committee.
Editorial Board of Osteoarthritis and Cartilage (Elsevier)
Editorial Boards of Osteoarthritis and Cartilage Open (Elsevier) and Osteoarthritis Imaging (Elsevier) and Scientific Reports (Springer Nature).
Published over 400 scientific articles, h-index: 78 (Scopus)

Associate professor of Experimental Cardiac Surgery at University of UKSH-Campus Luebeck in Germany

Adjunct Clinical Associate Professor of Surgery, Indiana University School of Medicine and Indiana University-Purdue University
Adjunct Associate Research Professor, Indiana University School of Medicine and Indiana University-Purdue University
Director, 3D Tissue Bioprinting Core at VA Medical Center

Professor, Baylor College of Medicine, Texas Children's Hospital
Managing Director at Baylor College of Medicine, Texas Children's Hospital

Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy).

His research has included Immunodeficiency Autoimmunity Neuro-endocrino-immunology Pharmacogenomics.

Based on this research and fellowship training he has received several awards and honors, such as:
Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001).

Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-? and IL-4 ".

Prof. Giuseppe Nigri is Professor of Surgery at the Sapienza University of Roma. His major interest is Surgical Oncology and Minimally Invasive Surgery. He is USMLE/ECFMG-certified. He trained in Italy and in the USA (Clinical and Research Fellow and Resident in General Surgery) at the Massachusetts General Hospital, Harvard Medical School, Boston, MA. He is a Fellow of the American College of Surgeons, Fellow of the Royal College of Surgeons and Fellow of the Society of Surgical Oncology. He has been a Member of the International Relation Committee and Chair of the Scholar Selection Subcommittee of the American College of Surgeons. He is also Fellow, Member and Committee member of SAGES, SSAT, SSO and the International Society of Surgery (ISS_SIC). He authored and co-authored more than 300 international scientific publications and he is a member of numerous and prestigious editorial boards (CV and bibliography at http://sapienza.giuseppenigri.it/cv/index).

Professor (Associate) at University of Padua

Stefano Palomba is a Professor of Obstetrics & Gynecology at Sapienza University of Rome (Italy) and Chief of the Unit of Obstetrics & Gynecology of the Grande Ospedale Metropolitano of Reggio Calabria (Italy) His main field of interest is reproductive medicine and surgery. He is Editor-in-Chief of Current Drug Therapy, Section Editor of Reproductive BioMedicine Online, and Associate Editor of the Journal of Ovarian Research. His total citation index is >12,000 with an H index >60.

Dr. Peichen Pan is a Distinguished Research Fellow and Doctoral Supervisor at the College of Pharmaceutical Sciences, Zhejiang University in Hangzhou, China. His research heavily focuses on computer-aided drug design, structural biology, and targeted therapeutics for cancers, particularly Glioma and Glioblastoma multiforme (GBM). 

Professor of Biochemistry (Full)
School of Medicine, University of Bari "Aldo Moro", Bari, Italy

Research Associate Professor, Microbiology, Immunology and Infectious Diseases
Scientific Director, Snyder Mouse Phenomics Resource laboratory
Full Member, Snyder Institute for Chronic Diseases

Dr. Aurel Popa-Wagner is affiliated to Department of Psychiatry, Medical University Greifswald, where Dr. Aurel Popa-Wagner is currently working as Professor. Dr. Aurel Popa-Wagner has authored and co-authored several national and international publications and also working as a reviewer for reputed professional journals. Dr. Aurel Popa-Wagner is having an active association with different societies and academies around the world. Dr. Aurel Popa-Wagner made his mark in the scientific community with the contributions and widely recognition from honourable subject experts around the world. Dr. Aurel Popa-Wagner has received several awards for the contributions to the scientific community. Dr. Aurel Popa-Wagner major research interest involves Neuroimaging, Neuroscience.  

Dr. Vikrant Rai is an Assistant Professor of Pathophysiology and Immunomodulation at the Western University of Health Sciences. His research explores the inflammatory aspects of chronic diseases, focusing on cardiovascular inflammation, diabetic foot ulcer healing, and tumor immunomodulation.  

Professor, Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT-USA
Adjunct professor, Roseman University of Health Sciences
The chief objectives of his lab investigations are to examine the involvement of cellular metabolism and oxidative stress signals in inflammation. He uses various genetic, biochemical and cell biological approaches to analyze inflammatory responses regulated by cellular lipid metabolites leading to secondary diabetic complications and cancer. He has published more than 140 peer reviewed articles. He is also serving as an editorial board member of several journals.   

Michael Retsky (PhD in Physics from University of Chicago) made a career change to cancer research thirty years ago. He is on staff at Harvard TH Chan School of Public Health and Angiogenesis Foundation, both in Boston. He is also on faculty at University College London. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. Retsky is Editor of a Nature/Springer book on breast cancer to be published in 2017 and Editor-in-Chief of the Journal of Bioequivalence and Bioavailability. He is a founder and on the Board of Directors of the Colon Cancer Alliance and has published more than 60 papers in physics and cancer. He was diagnosed with stage IIIc colon cancer in 1994. Based on his prior research on tumor growth and therapy he decided against using conventional maximum tolerated chemotherapy. Instead he used a low dose, long term therapy administered daily with a portable infusion pump and the usual colon cancer drug 5-fluorouracil. The therapy was non-toxic and apparently worked well since he did not relapse and it is now well beyond the period of risk of relapse. This was discussed with Judah Folkman and Tim Browder in 1996 and led to testing of this therapy in the Folkman lab. Results were published in 2000 by Browder et al and the therapy is now termed metronomic chemotherapy. The Browder et al Cancer Research 2000 paper is a citation classic. Both Folkman and Browder are deceased so Retsky (the cancer patient) is the only one left alive to relate the story of the initiation of metronomic chemotherapy. (See Retsky M. An argument for discovery-driven research: from physicist to cancer researcher. Ecancermedicalscience. 2014 Jul 3;8:ed38. doi:10.3332/ecancer.2014.ed38. eCollection 2014. PubMed PMID: 25075219; PubMedCentral PMCID: PMC4096027.)

Dr. Rizvi is a broadly trained scientist, educator, and healthcare contributor, equipped with extensive training and academic background in clinical and translational research spanning over 25 years. The nature of most of his professional experiences is industrial, academic, administration, and healthcare settings.

He has published over Published 210 peer-reviewed articles, including journal publications, book chapters, books, US patents, and oral/poster presentations. His publications include highly rated-articles and cover articles. He also serves on the Editorial Boards/Panels of different journals (in various capacities) and reviews manuscripts and books for over 185 well-known scientific publications (journals and books). Dr. Rizvi enjoys teaching, cooking, and practicing martial arts (Hakko-Ryu Jujutsu and Okinawan Goju Ryu Karate).

Dr. Richard Rosen came to New York Eye and Ear Infirmary of Mount Sinai (NYEE) in July 1986, as an Ophthalmology resident. He had previous training as a professional photographer and ophthalmic photographer for Dr. Morton Rosenthal and is a long time member of the Ophthalmic Photographers Society achieving Certified Retinal Angiographer status. He completed his residency in 1989 and his retinal fellowship, under Dr. Muldoon at the Infirmary in 1991 prior to joining the staff. During his time at NYEE, Dr. Rosen has been a mainstay of the teaching program and has been honored by graduating residents on numerous occasions for his devotion and dedication to teaching and patient care. During his fellowship Dr. Rosen served as Director of Medical Student Education and went on to serve as Program Director for the Department of Ophthalmology from 1992 – 2002. In 2002 he was named Vice-Chair of the Department and Director of Research and Surgeon-Director, Ophthalmology. Dr. Rosen has maintained a wide interest in vision and has been involved in basic science, translational and clinical projects. He has numerous grants especially in Retinal Imaging where he has achieved a well-deserved international reputation. He has authored over 100 peer-reviewed publications, numerous abstracts and lectures extensively locally, nationally and internationally. 

Professor of Biomaterials
Deputy School Director of Research and Innovation
CDT Co-Director Advanced Biomedical Materials

Professor Remo Castro Russo (PhD Immunology) is Head of Laboratory of Pulmonary Immunology and Mechanics from Departamento de Fisiologia e Biofísica at Federal University of Minas Gerais (UFMG), Belo Horizonte - Brazil. The central objective of our Lab is the study of the molecular mechanisms involved in pulmonary immunopathology (characterized by acute inflammatory response or chronic, infectious or sterile) and their effects on respiratory mechanics in experimental models of relevant diseases. Experimentally investigate the effects of pharmacological or genetic intervention as a tool for (proof of concept) preclinical validation of new targets and drug candidates in the context of Pulmonary Fibrosis, Influenza A H1N1 infection, Remote Lung Injury and Glucocorticoid-Resistant Asthma.

Bernhard RYFFEL is MD, PhD, Professor, INEM, UMR7355, CNRS, University, Orleans, France

Professor, Pediatric Hematology/Oncology/Stem Cell | Department of Pediatrics, Stanford University, Stanford, USA

Dr. Nitin K. Saksena has had a longstanding career in retrovirology and viral genetics. He was the head of the Retroviral Genetics Laboratory at the Centre for Virus Research, Westmead Millennium Institute, Westmead Hospital, and held an academic appointment at the University of Sydney . More recently, his affiliation has shifted to Victoria University in Melbourne, Australia .

He served as the editor of the comprehensive volume "Human Immunodeficiency Viruses: Biology, Immunology and Molecular Biology" (Medical Systems SpA, Genoa, Italy, 1998), which featured over 40 contributing authors and provided multidisciplinary insights into HIV pathogenesis 

Dr. Hiroyuki Sakurai is a faculty member in the Division of Respiratory Surgery at Nihon University School of Medicine in Tokyo, Japan . He has been active in clinical and translational research in thoracic oncology, with a particular focus on early-stage lung cancer.

Alejandro K. Samhan-Arias is an Associate Professor and coordinator of the Master’s in Biotechnology in the Biochemistry Department of the School of Medicine, Universidad Autónoma de Madrid (UAM), and the Instituto de Investigaciones Biomédicas 'Sols-Morreale' (CSIC). He is dedicated to comprehending both the beneficial and harmful properties of free radicals and reactive oxygen and nitrogen species, with a particular focus on reactions occurring in biological membranes. His primary interests also encompass the physical biochemistry and structural biology of electron transfer proteins, particularly metalloproteins, whose function might be altered by specific microenvironments, such as those provided by specific lipid membrane domains. He has expertise in a multitude of biophysical and spectroscopic techniques.

Adjunct Associate Professor, Department of Medicine (Cardiology)

Adjunct Associate Professor, Department of Molecular Pharmacology

Erik Schadde, MD, FACS, FEBS (HPB), trained in general surgery in Boston, in transplantation at the University of Wisconsin-Madison, was an attending in transplant surgery at University of Kansas Kansas City and became the head of liver transplantation at Saint Louis University Medical Center in 2009.

To develop his clinical and research interests in complex liver surgery involving induction of liver regeneration, Schadde moved to the Swiss HPB center of the University of Zurich in 2010 as a consultant surgeon and rapidly became the head of the HPB fellowship program there. He performed the first procedures of a novel method to induce rapid liver regeneration at the Zurich center for liver surgery, ALPPS. The procedure was pioneered by a group of German surgeons to help patients with extensive tumors who would otherwise not be candidates for liver surgery. Based on the success of the innovation, Schadde, together with his mentor Pierre-Alain Clavien, initiated a worldwide registry to assess the outcomes of this innovation and is regarded to be an expert of complex liver surgery involving the induction of liver regeneration prior to resection. He has authored several papers on the ALPPS procedures, is the authors of several textbook chapters on liver surgery and is a reviewer to a number of international journals in the field of hepatobiliary and transplant surgery, as well as a speaker on this topic in national and international venues.

In 2015, he was recruited to RUSH University to help with the development of a new center for complex liver surgery in Chicago. In his laboratory research, he is specifically interested in using the methods to induce liver growth in transplantation to make small pieces of donor organs into livers big enough to support a liver transplant recipient.

Schadde is involved with RUSH's development of pioneering, life-changing treatments for fibrolamellar carcinoma, a rare pediatric cancer. Rush physicians employ novel immunotherapeutic combinations and portal vein/double vein embolization, a leading-edge technique used at RUSH in greater volume than anywhere in North America. RUSH also treats the largest number of all cases of this rare type of cancer in the United States.

In 2019 Schadde initiated the Chicago LIVERMET Symposium, hosted at RUSH, which featured the latest innovations in the treatment of liver metastases. The conference was attended by expert clinicians who diagnose and treat metastatic liver disease across the United States.

Dr. Andrea Schlegel is an academic transplant surgeon at Cleveland Clinic specialized in liver transplantation and hepatobiliary surgery. Dr. Schlegel’s interests include both, experimental and clinical research with a focus on organ preservation to improve the utilization of human organs. To ensure utmost safety for transplant recipients, Dr. Schlegel’s lab explores underlying mechanisms of mitochondrial injury and protection throughout the entire journey of an organ from the donor to the recipient.

Dr. Schlegel obtained her medical degree with Honors from the Justus-Liebig-University Giessen (Germany). She completed her research fellowship and residency at the University Hospital Zurich (Switzerland), where she also served as Chief Resident and Staff Surgeon with a focus on quality improvement and patient safety in abdominal surgery and transplantation. She went on to complete her Transplant Surgery and Hepato-Pancreatico-Biliary Surgery fellowship training at Queen Elizabeth University Hospital Birmingham (United Kingdom) and was awarded with a Staff position as Transplant Surgeon before moving to Italy (Careggi Hospital Florence and Milan Policlinico), where she achieved the “National Scientifica Qualification” as Full Professor (06/C1 - General Surgery). 

Since 2011 her research is focused on a broad range of topics including dynamic organ preservation in context of transplantation, the development of new markers to predict organ viability, and underlying mechanisms of ischemia and reperfusion injury triggered by mitochondrial injury and dysfunction.

Dr. Schlegel serves as Associated Editor and Reviewer in more than 15 leading journals in the field of surgery and transplantation and has various international collaborations worldwide with an average number of 20 invited lectures and presentations per year.

Dr. Schlegel is board certified in General Surgery (FMH), Transplant Surgery (EBSQ/UEMS) and Hepato-Pancreatico-Biliary Surgery (EBSQ/UEMS) and obtained a Master in Business Administration (MBA, specialized in International Healthcare Management) from the Robert Kennedy College (Switzerland) and University of Cumbria (United Kingdom).

Michael Schulder, MD is the Director of the Brain Tumor Center at the Northwell Neuroscience Institute, and Vice-Chairman of Neurosurgery at the North Shore University Hospital and LIJ Medical Center campus of Northwell Health, and Professor of Neurosurgery at the Zucker School of Medicine at Hofstra/Northwell. Dr. Schulder is the founding (and current) Program Director of the neurosurgical training program at the Zucker School of Medicine. He also serves as the Co-Director of the Northwell Health Center for Stereotactic Radiosurgery and Radiation Therapy. Dr. Schulder received his MD degree from the College of Physicians and Surgeons of Columbia University in 1982. He completed his residency training in neurosurgery at the Albert Einstein College of Medicine, and trained in stereotactic neurooncology at Harvard Medical School and at the University of Florida, Gainesville. Dr. Schulder is an elected member of the American Academy of Neurological Surgery, and of the Society of Neurological Surgeons. Dr. Schulder has authored and co-authored over 100 peer-reviewed publications, along with numerous book chapters and meeting presentations. He is the editor of the Handbook of Stereotactic and Functional Neurosurgery, and a co-editor of Functional Neurosurgery. Dr. Schulder is the immediate Past President of the World Society for Stereotactic and Functional Neurosurgery, a Director of the American Association of Neurological Surgeons (AANS), which he also serves as the Historian, and the Secretary-Treasurer of the New York Neurosurgery Society. He has served as President of the American Society for Stereotactic and Functional Neurosurgery, the Intraoperative Imaging Society, and as editor-in-chief of AANS Neurosurgeon, the socioeconomic publication of the AANS. He is an editorial board member of the Journal of Neurosurgery, Neurosurgery, the Journal of Neurooncology, and of Stereotactic and Functional Neurosurgery, and a reviewer for many other peer-reviewed journals. Dr. Schulder's academic interests have focused on applications of image guidance to improve outcomes in brain surgery, in particular for patients with brain tumors.

Professor, Department of Cell Stress Biology, Department of Head and Neck Surgery, Roswell Park Cancer Institute

Dr Vishal is a general surgeon trained in open, laparoscopic and robotic hepatobiliary and pancreatic surgery and diagnostic foregut and hindgut endoscopies. He is involved in undergraduate and postgraduate teaching and training; and received hospital, cluster and medical school level various teaching awards. He serves as Clinical Educator Lead(Medical) and Director of Surgical Science Training Centre at Tan Tock Seng Hospital.

Professor Yang Shen serves as Member of the Party Committee and Vice President of Zhongda Hospital Affiliated to Southeast University, Chair of the Department of Obstetrics and Gynecology, Director of the Institute for Women’s Life and Health, and Director of the Women’s Pelvic Floor Health Management Center, all at Southeast University. He was a Visiting Scholar at the University of Arizona Medical Center from 2014 to 2015.

Dr Shu graduated from Xiangya School of Medicine with PhD in Pathobiology (1999) and was then awarded a Wellcome Trust Travelling Fellowship to work at the University of Glasgow (1999-2001), where he worked on the human pathogen Paracoccidioides brasiliensis.

From July 2001, he moved to MRC Human Genetics Unit, to work as an Investigator Scientist (2001-2005) and then Senior Investigator Scientist, focusing on the disease mechanisms of retinitis pigmentosa (RP) and age-related macular degeneration (AMD).

In February 2010 he joined the Department of Life Sciences to continue his studies on the pathogenesis of retinal degeneration.

Associate Professor of Biochemistry, College of Medicine, Kuwait University

Professor, Catholic University of Brasilia

Dr. Michiel Sinaasappel, MSc, PhD, is a researcher in the Department of Clinical Physics and Instrumentation at the Netherlands Cancer Institute in Amsterdam. His work focuses on respiratory physiology, specifically developing airway climate assessment tools and evaluating heat and moisture exchangers for laryngectomy patients. He also studies pleural pressure dynamics in patients with malignant pleural effusion.

Prof. M.D. Marc D. de Smet is currently a specialist in opthalmology at Clinique Bois-Cerf. Prof. M.D. Marc D. de Smet is also the Chief Physician of Vitreo-Retinal Surgery at the Department of Ophthalmology, ZNA Middelheim, Antwerp, Belgium. Prof. M.D. Marc D. de Smet is also a Professor of Ophthalmology at the Department of Ophthalmology, Academic Medical Center, University of Amsterdam. And Prof. M.D. Marc D. de Smet is the Director of the Vitreo-Retinal and Uveitis Division, Department of Ophthalmology, ZNA Middelheim, Antwerp, Belgium. Prof. M.D. Marc D. de Smet is a visiting professor, Department of Ophthalmology, University of Gent, Belgium.

Professor (Full), School of Psychology, Centre for Occupational and Health Psychology, Cardiff University 

Dr. Srivastava has served as a professor and eminent scientist in major US Universities. He has been proclaimed as an eminent scholar by the Kansas Bioscience Authority, and endowed professor at KUMED. The list of accolades and awards conferred on him is huge and rightly deserved too as he has been a pioneer in some trailblazing subjects when it comes to research. He has received national merit awards and scholarships during his graduate and postgraduate studies. He was awarded fellowships at the National Institutes of Health, and the National Academy of Sciences, USA, and a Career Development Award from the US Army. Furthermore, he has been rightly touted as a Scholar by Louisiana Cancer Research Consortium.

Dr. Elisavet Stavropoulou was affiliated with the Department of Internal Medicine and Department of Infectious Diseases.  Her research interests mainly focus on infectious diseases, microbial ecology, health, disease, microbiota, hygiene, antibiotics, probiotics, diet, and intestine. Her scientific output includes 54 publications in various journals with an h-index of 20(Scopus, February 2024). Actually, she is working for the Greek National Health Organization(EODY)

Buzz has a lifelong passion for asking What is a better, faster way to do this? Never content with the status quo, he has spent over 20 years exploring the endless ways data can be harnessed to simplify and automate work for patients, providers, and all others who play a role in healthcare delivery.

With diverse leadership experience in health research, healthcare operations, and clinical trial logistics—and with over 400 publications to his name—Buzz has developed a deep understanding of the science and practice of putting data to work.

Prior to co-founding Medcurio, Buzz served as Chief Research Officer and Founder of Research, Development and Dissemination at Sutter Health; Associate Chief Research Officer and Founder of the Center for Health Research at Geisinger Health System; Vice President of Research and Development at PCS Health; and Co-Founder and President of a clinical trials and survey research company.

Buzz has expertise in digital solutions, machine learning, and practice-based rapid learning, and holds a PhD in Epidemiology from the Johns Hopkins Bloomberg School of Public Health, where he currently serves as an adjunct professor.

Dr. Srini Subramaniam is an Associate Professor at The Scripps Research Institute in Jupiter, Florida. He obtained his PhD in 2004 from the University of Heidelberg, Germany, where he worked on the molecular signaling that triggers neuronal death. At Johns Hopkins University for his postdoctoral research, he addressed the mechanisms for selective neuronal degeneration, focusing Huntington’ s and Parkinson’s disease, which continues to guide his research today.

A nationally recognized pulmonologist and intensivist with 35+ years of experience, Dr. Surani combines academic medicine, public service, and innovation in critical care, sleep health, and medical education.

Current Positions:

• Adjunct Clinical Professor, Texas A&M Health Science Center
• Past Program Director, Pulmonary & Critical Care Fellowship, Corpus Christi
• Former Secretary, CHEST Foundation Board of Trustees
• Member, Board of Advisors, CHEST

• Past Trustee, CHEST Foundation
• Reviewer for 20+ journals | Author of 400+ scientific publications

Ana María Sánchez (ReserchearID N-2731-2017) studied Biology at Valencia University. She obtained her Master's Degree (1993) and PhD (1997) at the University of Bristol (UK). As a postdoctoral, Ana spent 3 years at the University of California San Francisco (UCSF, USA); 1 year at University of Padova (Italy). She was a researcher in the CIPF institute (Valencia, Spain). Ana joined the University of Jaume I (Castellon, Spain) in September 2012, where she coordinates the Neurobiotechnology research group. Ana has published over 50 papers, with 1700 citations and h-index of 22. Her current interest is the development of new biotechnology tools, (AAV derived particles, DNA nanoparticles) in synergy with pharmacological interventions, aiming to significantly improve brain-mental health. Ana has recently joined the INAM where she collaborates in the development of novel plastic-degrading enzymes.

Professor, Gastroenterology and Hepatology, Medicine and Surgery Program

2018-09-01 to present | Professore Associato - SSD MED /49 Scienze Tecniche Dietetiche Applicate (Dipartimento di Scienze Biomediche per la Saluite)

Dr. Luca Testarelli is an associate professor of Dental Restorative and Endodontics at Sapienza University of Rome, and Oral Care in School of Dental Hygienist in Sapienza University of Rome since 2006. His career began in 2000 with the degree cum laude as Doctor of Dental Sciences at Sapienza University of Rome and followed by a PhD degree (2004) and specialization in Orthognathodontics (2008). Since 2011 he has practiced as a dentist in the Dental Clinic of Policlinico Umberto I’s Hospital of Rome.
He is member of several scientific national and international associations and member of editorial boards of several dental scientific journals. His research interests and activity are mostly related to dentistry and specifically focused on lines of research, such as: cross-infection control in Dentistry, experimental in vitro and in vivo evaluation of dental materials used in endodontic practice, particularly related to nickel-titanium rotary instruments, sealers and irrigants, experimental in vitro and in vivo evaluation of dental materials for dental hygienists, implantology and 3D dental radiology.

Sathish Thirunavukkarasu is an Assistant Professor at the Department of Family and Preventive Medicine, Emory School of Medicine. Sathish completed his Medical Degree, Diploma in Family Medicine, and Master's Degree in Public Health in India and received a PhD in Diabetes Epidemiology from the University of Melbourne in Australia. After his PhD, he did two years of Postdoctoral training at Nanyang Technological University in Singapore and three more years at McMaster University in Canada.

His primary research focuses on the epidemiology of type 2 diabetes and its prevention by developing novel interventions. He is also keen on translating the evidence from research into clinical and public health practice. Sathish has published research articles in very high-impact, leading medical and global health journals such as Nature Reviews Endocrinology, The Lancet Diabetes & Endocrinology, The Lancet Global Health, Diabetes Care, and PLoS Medicine as the lead author.

Daniele Tibullo is an Associate Professor in biochemistry in the Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, Italy. He completed his Ph.D. in the Division of Hematology, AOU "Policlinico - Vittorio Emanuele", University of Catania, Catania, Italy, with broad research interests in cancer biology, metabolism in hematologic diseases, flow cytometry, clinical hematology, cell proliferation, and cells. Since the beginning of his career, his research activity has focused on the role of heme oxygenase 1, the mechanisms connected to iron metabolism, and the interaction between tumor cells and immune cells. In his scientific work, studies on metabolic consequences in response to treatments and the mechanisms of resistance to therapy have particular importance, particularly concerning the metabolic fitness of solid and hematological tumors. His research activity has primarily focused on preclinical research in mouse and zebrafish models and in vitro using human and mouse cell models. Among his most significant lines of research, studies on the antioxidant and anti-inflammatory roles of alpha lipoic acid have a prominent place.

Specialized in Obstetrics and Gynecology at the University Medical School of Bari. Professional Training in Gynecological Laparoscopy at the Center for Advanced Pelvic Surgery and National Center for Endometriosis (European Gynecologic Endoscopic School), Malzoni Medical Center, Avellino, Italy, directed by Dr Mario Malzoni. National Authorirization as Associate Professor in Obstetrics and Gynecology.

President of Fondazione Paolo Procacci. Scientific activities: Former President of the European Pain Federation (EFIC); former President of the Italian Association for the Study of Pain (ASID). Academic activities: Former Full Professor, Anesthesia and Pain Medicine, UNIVAQ, Italy; former Chairman, Dept. of Health and Medical Sciences at the same University. At the moment is Honorary Professor of Pain Medicine at the University of Baghdad, Baghdad, Iraq.

Dr. Jiong-Wei Wang obtained his PhD degree in Medicine from the Leiden University Medical Centre, The Netherlands, in 2013. After post-doctoral training at University Medical Center (UMC) Utrecht (The Netherlands) and National University of Singapore, he started his faculty position as an Assistant Professor in July 2019 at the National University of Singapore. Besides Department of Surgery, he holds a joint appointment at the Department of Physiology for teaching. For research, he is a Principal Investigator at the Cardiovascular Research Institute (CVRI; National University Heart Centre Singapore) and the Nanomedicine Translational Research Program (Yong Loo Lin School of Medicine). His research has been supported by National Medical Research Council (NMRC), Ministry of Education (MOE) and NUS/NUHS among others. He was awarded three times the “Young Investigator Award” by the International Society on Thrombosis and Haemostasis (ISTH), twice travel awards by the European Society of Cardiology (ESC), the Outstanding Mentor Award in 2019 by Wong Hock Boon Society–Singapore Medical Association (SMA) Charity Fund (WHBS-SMACF), and the Young Researcher of the Year Award for 2023. For service, Dr. Wang is currently the Chairperson for Department Safety & Health and a committee member for Safety & Health at Yong Loo Lin School of Medicine.

Professional service and membership

Member of European Society of Cardiology
Editorial board member for Frontiers in Cardiovascular Medicine, Heliyon, International Journal of Drug Discovery and Pharmacology, Journal of Laboratory and Precision Medicine; invited guest editor for Frontiers in Immunology, Biology, among others.
Reviewer for funding bodies (grants) and prestigious scientific journals, including Advanced Drug Delivery Reviews, Small, Theranostics, Matter, Journal of Extracellular Vesicles, Cardiovascular Research, Journal of Controlled Release, among others.

Dr. Stuart S. Winter is a pediatric hematologist-oncologist in Albuquerque, New Mexico and is affiliated with Children's Minnesota. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice for more than 20 years. Dr. Stuart S. Winter accepts Aetna, Cigna, Blue Cross - see other insurance plans accepted. Dr. Stuart S. Winter is highly recommended by patients.

Dr. Albert Wolkerstorfer is a Medical Specialist in Dermatology at the University of Amsterdam, specializing in laser dermatology, pigment disorders, and innovative skin treatments. His research focuses on clinical and preclinical laser techniques, advancing therapeutic approaches for various dermatological conditions.

Dr. Wolkerstorfer is affiliated with Amsterdam UMC, where he leads studies on laser treatments for skin disorders, pigment cell transplantation, and outcome development in dermatology. His expertise extends to vitiligo, keloids, and vascular anomalies, contributing to improved treatment protocols for complex skin conditions. His work has been instrumental in refining laser-based interventions, ensuring precision and efficacy in dermatological care.

He has co-authored numerous peer-reviewed publications, including studies on home-use hyaluronic acid jet injectors, vitiligo treatment strategies, and keloid growth patterns. His research has helped shape best practices in laser dermatology, optimizing patient outcomes through evidence-based approaches. His contributions to pigment disorder management have influenced treatment guidelines, particularly in non-segmental vitiligo and pigment cell transplantation.

Beyond his research, Dr. Wolkerstorfer is actively involved in medical education, mentoring dermatology trainees and specialists in laser techniques and pigment disorder treatments. He collaborates with international experts to advance dermatological innovations, ensuring that emerging therapies align with patient needs and clinical efficacy.

Dr. Wolkerstorfer is also a member of the Translational Research Editorial Board, contributing to discussions on dermatological advancements and clinical applications. His expertise in laser dermatology, pigment disorders, and innovative skin treatments continues to shape the field, improving therapeutic options for patients with complex dermatological conditions.

Professor, The Ph.D. Program for Translational Medicine
Joint-Appointment Professor, Graduate Institute of Biomedical Informatics
Joint-Appointment Professor, International Ph.D. Program for Translational Science
Joint Appointment Professor, International Master Program for Translational Science
Member, TMU Research Center of Cell Therapy and Regeneration Medicine
Member, Taipei Heart Institute (THI), Taipei Medical University

Professional researcher with extensive experience in pharmacology & toxicology, nanotechnology, drug delivery, and cancer therapeutics.

Dr. Yin Jiye, male, born on May 10, 1982, holds an M.D. and Ph.D. He is a Principal Investigator and Doctoral Supervisor at the Institute of Clinical Pharmacology, Xiangya Hospital, Central South University. He has received numerous honors, including the Second Prize of the National Science and Technology Progress Award, the First Prize of the Natural Science Award of Hunan Province, the C.N.S.-Servier Young Pharmacologist Award of the Chinese Pharmacological Society, the “Furong Scholar” Young Scholar Award, and the “Huxiang Young Talents” Award. He has led over 20 research projects, including a Major National Science and Technology Project for New Drug Innovation and Development, five projects funded by the National Natural Science Foundation of China, and a project supported by the Hunan Provincial Natural Science Fund for Distinguished Young Scholars. As first or corresponding author, he has published 55 papers in leading domestic and international journals such as The Lancet and Clinical Cancer Research, and co-authored 173 additional papers, including three ESI top 1% highly cited papers. His work has been cited over 4,000 times in journals including Nature Reviews Genetics and Nature Reviews Endocrinology, giving him an H-index of 38. He is a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), the international authoritative guideline for pharmacogenomics. He serves as a standing committee member of the Pharmacogenomics Committee of the Chinese Pharmacological Society, a standing committee member of the Youth Committee of the Drug Metabolism Committee of the Chinese Pharmacological Society, and a vice-chairman of the Tumor Pharmacology Committee of the Hunan Pharmacological Society. He is an Associate Editor for Frontiers in Pharmacology, and serves on the editorial boards of six SCI-indexed journals, including Drug Resistance Updates and Scientific Data. He is a peer reviewer for over 60 SCI journals, including Molecular Cancer, Theranostics, and Biochimica et Biophysica Acta - Reviews on Cancer. He holds three granted patents among seven filed Chinese invention patents. He has been invited to deliver over 30 plenary or keynote lectures at international and domestic conferences. His primary research interest is individualized therapy.

Hiroshi Yoshida, M.D., Ph.D., FACP, FAHA is Professor of Department of Laboratory. Medicine, The Jikei University School of Medicine, The Jikei University Kashiwa Hospital

Mustafa Younis is a tenured Professor at Jackson State University with a concentration in health policy and management, health economics and finance, and global health. His academic training includes public health, economics and business administration.
His research focuses on global health, health economics, health-care finance, health policy, quality, efficiency and international health systems. He has published and served widely in professional roles related to health administration, public health education and policy-oriented health services research.

Dr. Yu got his Ph.D. degree from Chinese Academy of Medical Sciences & Peking Union Medical College in 2003, followed with postdoctoral trainings at University of Pennsylvania (2004 – 2006) and Thomas Jefferson University (2006 – 2009). After a faculty appointment at the rank of Assistant Professor of Cancer Biology (2009-2011) at Thomas Jefferson University, Dr.Yu joined Tongji University School of Medicine in 2012, focusing on non-coding RNA regulation on cancer stem cells and cancer metastasis..

Dr. Zhao is Director of Gynecology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine. He contributed to the international textbook Hysterectomy: A Comprehensive Surgical Approach (Kiel University). He is a Chief Translator of Female Pelvic Surgery into Chinese. He has published over 30 peer-reviewed papers as first or corresponding author in leading journals. He has secured multiple national (NSFC) and provincial-level research grants.

Professor at Chongqing Medical University, State Key Laboratory of Ultrasound in Medicine and Engineering

Dr. Associate Professor, Medical Microbiology and Infection Prevention

Dr. Marco Zaffanello, specialized in Pediatrics, is a University Researcher and provides medical assistance at the Pediatric Clinic. In particular, he deals with respiratory sleep disorders and polysomnography in pediatric age.

Dr. Pavlos Zarogoulidis, M.D, Ph. D Director of Pulmonary Department, ``General Clinic Euromedica`` Private Hospital, Thessaloniki, Greece have three MS.c in ``Clinical Pharmacology``, ``Sleep Medicine`` and  ``Thyroid Gland Disease and Treatment ``and my Ph. D is regarding inhaled chemotherapy for lung cancer. In my everyday practice I perform diagnosis for lung cancer with bronchoscopy, radial and convex probe endobronchial ultrasound and medical thoracoscopy. 

Lei Zhang is an associate professor at the College of Optical Science and Engineering, Zhejiang University. He has joined Zhejiang Lab as a Principal Investigator. Lei Zhang obtained a PhD (in Chemistry) from the Zhejiang University. His research interests span from the optical micro/nanofiber sensors to multifunctional and multimodal tactile sensing devices. He published more than 40 papers in peer reviewed scientific journals including iScience, Advanced Materials, Nano Letters, ACS Sensors, Lab on a Chip, Nanoscale and Optics Letters. He filed 5 Chinese patents and wrote 1 book chapter.

Professor – Tianjin First Central Hospital / Nankai University

Chief Physician (Director Physician) – Organ Transplant Center, Tianjin First Central Hospital

Doctoral Supervisor – Nankai University

Vice President (former) – Tianjin First Central Hospital

Deputy Director – Organ Transplant Center, Tianjin First Central Hospital

Director of Scientific Research (former) – Tianjin First Central Hospital

Dr. Zhong's research focuses on hepatobiliary surgery, particularly hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Key areas include:

• HBV-Related Hepatocellular Carcinoma: Antiviral therapy, surgical outcomes, recurrence prevention, and prognostic factors 

• Hepatic Surgery: Radical hepatectomy, conversion therapy for intermediate-advanced HCC, and surgical treatment of extrahepatic metastases 

• Adjuvant Therapy: Immunotherapy, immune checkpoint inhibitors (ICIs), and nucleos(t)ide analogues for postoperative patients at high risk of recurrence 

• Combination Therapies: Transarterial chemoembolization (TACE) combined with antiviral therapy or systemic therapy 

• Translational Research: miRNA regulation (miR-17-5p, TGFβR2) in HCC epithelial-mesenchymal transition (EMT) 

Professor Zhu Pingping has studied the microenvironmental regulation and epigenetic regulation of long-term stem cells (adult stem cells and tumor stem cells), identified multiple stemness regulatory factors and regulatory pathways of tumor stem cells and intestinal stem cells, and discovered a new model of immune microenvironment regulation of intestinal stem cells. Professor Zhu Pingping has successively presided over the China Association for Science and Technology Young Talent Support Project, the Postdoctoral Innovation Talent Support Program, the National Natural Science Foundation of China General Project, and the Excellent Youth Project. He has published more than ten papers as the first author or general author in journals such as Nat Immunol, Nat Cell Biol, Nat Struct Mol Biol, J Clin Invest and Nat Commun, and has published more than 30 SCI articles in total, with a total impact factor of more than 300 and a citation rate of more than 1,000 times in two years. He has won the Special Award of the President of the Chinese Academy of Sciences and the First Prize of Beijing Science and Technology Progress.

Dr. Manuel R. Benito de Las Heras is an emeritus professor at the Complutense University of Madrid (UCM).  His laboratory's foundational work in molecular biology and metabolism has heavily contributed to scientific literature, with over 250 published works cited widely.  

Dutch and European Patent Attorney, UPC Representative
Scientist, Amsterdam University Medical Center, Netherlands, 2007-2016.